Advanced Biomedical Research · 2014 · 16 citations · 15 references
These findings suggest the inhibition of miR-92a as a novel approach for treatment of Acute Promyelocytic Leukemia (APL).
15
Down-Regulation of miR-92 in Human Plasma Is a Novel Marker for Acute Leukemia Patients
Masami Tanaka, Kosuke Oikawa, Masakatsu Takanashi et al. · PLoS ONE · 2009 · 295 citations · Full text